Cited 8 time in
An Improved In Vitro Blood-Brain Barrier Model for the Evaluation of Drug Permeability Using Transwell with Shear Stress
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Junhyeong | - |
| dc.contributor.author | Shin, Seong-Ah | - |
| dc.contributor.author | Lee, Chang Sup | - |
| dc.contributor.author | Chung, Hye Jin | - |
| dc.date.accessioned | 2024-02-13T06:30:27Z | - |
| dc.date.available | 2024-02-13T06:30:27Z | - |
| dc.date.issued | 2024-01 | - |
| dc.identifier.issn | 1999-4923 | - |
| dc.identifier.issn | 1999-4923 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/69642 | - |
| dc.description.abstract | The development of drugs targeting the central nervous system (CNS) is challenging because of the presence of the Blood-Brain barrier (BBB). Developing physiologically relevant in vitro BBB models for evaluating drug permeability and predicting the activity of drug candidates is crucial. The transwell model is one of the most widely used in vitro BBB models. However, this model has limitations in mimicking in vivo conditions, particularly in the absence of shear stress. This study aimed to overcome the limitations of the transwell model using immortalized human endothelial cells (hCMEC/D3) by developing a novel dish design for an orbital shaker, providing shear stress. During optimization, we assessed cell layer integrity using trans-endothelial electrical resistance measurements and the % diffusion of lucifer yellow. The efflux transporter activity and mRNA expression of junctional proteins (claudin-5, occludin, and VE-cadherin) in the newly optimized model were verified. Additionally, the permeability of 14 compounds was evaluated and compared with published in vivo data. The cell-layer integrity was substantially increased using the newly designed annular shaking-dish model. The results demonstrate that our model provided robust conditions for evaluating the permeability of CNS drug candidates, potentially improving the reliability of in vitro BBB models in drug development. © 2023 by the authors. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
| dc.title | An Improved In Vitro Blood-Brain Barrier Model for the Evaluation of Drug Permeability Using Transwell with Shear Stress | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.doi | 10.3390/pharmaceutics16010048 | - |
| dc.identifier.scopusid | 2-s2.0-85183119006 | - |
| dc.identifier.wosid | 001151263400001 | - |
| dc.identifier.bibliographicCitation | Pharmaceutics, v.16, no.1 | - |
| dc.citation.title | Pharmaceutics | - |
| dc.citation.volume | 16 | - |
| dc.citation.number | 1 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | ABC TRANSPORTERS | - |
| dc.subject.keywordPlus | DIFFERENTIATION | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordAuthor | annular shaking dish | - |
| dc.subject.keywordAuthor | blood-brain barrier | - |
| dc.subject.keywordAuthor | hCMEC/D3 | - |
| dc.subject.keywordAuthor | immortalized human brain microvascular endothelial cell | - |
| dc.subject.keywordAuthor | in vitro BBB model | - |
| dc.subject.keywordAuthor | permeability | - |
| dc.subject.keywordAuthor | shear stress | - |
| dc.subject.keywordAuthor | transwell | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
